Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns
Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most oversold biotech stocks to invest in. Soleno Therapeutics, Inc.
Soleno Therapeutics Inc (SLNO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,577,777 | $174,257,725 | +26% | 2.25% |
| 2. | Vivo Capital Albert Cha And Frank Kung | 2,278,203 | $154,006,523 | -43% | 12.39% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 1,401,576 | $94,746,538 | -61% | 0.15% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,350,000 | $91,260,000 | +122% | 4.46% |
| 5. | Braidwell LP Alex Karnal | 1,281,989 | $86,662,456 | 2.57% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 250,000 | $5,000,000.00 | 3,074,542 | 2023-09-28 | Filing | |
| $21.00 | 36,939 | $775,719.00 | 2,824,542 | 2023-09-26 | Filing | |
| $20.03 | 117,996 | $2,363,459.88 | 2,787,603 | 2023-09-26 | Filing | |
| $19.11 | 88,685 | $1,694,770.35 | 2,669,607 | 2023-09-26 | Filing | |
| $18.24 | 52,691 | $961,083.84 | 2,580,922 | 2023-09-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.76 | 3,830 | $316,970.80 | 13,206 | 2025-07-01 | Filing | |
| $84.25 | 266 | $22,410.50 | 17,036 | 2025-06-24 | Filing | |
| $70.11 | 3,782 | $265,156.02 | 27,036 | 2025-04-01 | Filing | |
| $71.55 | 5,937 | $424,797.10 | 6,500 | 2025-03-28 | Filing | |
| $66.95 | 23,475 | $1,571,716.98 | 28,143 | 2025-03-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,999,682 | $540,778,476 | 0.03% | |
| 2. | 6,056,339 | $409,496,314 | 0.19% | |
| 3. | 3,492,252 | $236,076,235 | 0% | |
| 4. | 2,807,149 | $189,763,272 | 0% | |
| 5. | 2,312,095 | $156,297,621 | 0.03% |
News See All
9 Oversold Biotech Stocks to Invest In
Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value and healthcare.
Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the cheap US stocks to buy according to analysts.
10 Cheap US Stocks to Buy According to Analysts
On November 13, Carol Schleif, BMO private wealth chief market strategist, joined 'Squawk Box' on CNBC to discuss the latest market trends, state of the economy, and takeaways from earnings season.
Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings
Soleno Therapeutics extended its losing streak to a 5th consecutive day on Wednesday, slashing 26.59 percent to close at $46.87 apiece as investors appeared to have priced in a strong earnings performance...
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Soleno Therapeutics Third Quarter 2025 Financial and Operating Results Conference Call and webcast. [Operator Instructions].
Soleno Therapeutics, Inc. (SLNO): A Bull Case Theory
We came across a bullish thesis on Soleno Therapeutics, Inc. on X.com by seedy19tron. In this article, we will summarize the bulls’ thesis on SLNO.
Goldman Sachs Initiates Coverage of Soleno Therapeutics (SLNO) With a Buy Rating
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best healthcare stocks with the highest upside. Goldman Sachs initiated coverage of Soleno Therapeutics, Inc.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best biotech stocks with high potential.
Hedge Fund Resource Center Billionaire Hedge Funds
